Annual Cash & Cash Equivalents
$3.45 M
-$6.96 M-66.87%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual cash & cash equivalents is $3.45 million, with the most recent change of -$6.96 million (-66.87%) on December 1, 2023.
- During the last 3 years, XRTX annual cash & cash equivalents has risen by +$3.31 million (+2467.16%).
- XRTX annual cash & cash equivalents is now -76.68% below its all-time high of $14.79 million, reached on December 31, 2021.
Performance
XRTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.30 M
-$777.80 K-25.27%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly cash and cash equivalents is $2.30 million, with the most recent change of -$777.80 thousand (-25.27%) on September 1, 2024.
- Over the past year, XRTX quarterly cash and cash equivalents has dropped by -$1.15 million (-33.27%).
- XRTX quarterly cash and cash equivalents is now -84.53% below its all-time high of $14.87 million, reached on December 1, 2021.
Performance
XRTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XRTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.9% | -33.3% |
| 3 y3 years | +2467.2% | -70.9% |
| 5 y5 years | +1706.0% | -70.9% |
XRTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.7% | at low | -84.5% | at low |
| 5 y | 5-year | -76.7% | +7578.6% | -84.5% | +5024.1% |
| alltime | all time | -76.7% | >+9999.0% | -84.5% | >+9999.0% |
XORTX Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.30 M(-25.3%) |
| Jun 2024 | - | $3.08 M(-19.7%) |
| Mar 2024 | - | $3.84 M(+11.2%) |
| Dec 2023 | $3.45 M(-66.9%) | $3.45 M(-32.0%) |
| Sep 2023 | - | $5.07 M(-17.8%) |
| Jun 2023 | - | $6.16 M(-22.1%) |
| Mar 2023 | - | $7.91 M(-24.2%) |
| Dec 2022 | $10.41 M(-29.6%) | $10.43 M(+17.3%) |
| Sep 2022 | - | $8.89 M(-14.6%) |
| Jun 2022 | - | $10.42 M(-16.2%) |
| Mar 2022 | - | $12.42 M(-16.5%) |
| Dec 2021 | $14.79 M(>+9900.0%) | - |
| Dec 2021 | - | $14.87 M(+279.5%) |
| Sep 2021 | - | $3.92 M(-5.6%) |
| Jun 2021 | - | $4.15 M(-13.3%) |
| Mar 2021 | - | $4.79 M(+3465.1%) |
| Dec 2020 | $134.30 K(+199.1%) | $134.30 K(-5.0%) |
| Sep 2020 | - | $141.30 K(-38.4%) |
| Jun 2020 | - | $229.50 K(-36.3%) |
| Mar 2020 | - | $360.30 K(+702.4%) |
| Dec 2019 | $44.90 K | $44.90 K(-45.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $82.00 K(+8.3%) |
| Jun 2019 | - | $75.70 K(-29.2%) |
| Mar 2019 | - | $106.90 K(-44.0%) |
| Dec 2018 | $190.90 K(+287.2%) | $190.90 K(-36.5%) |
| Sep 2018 | - | $300.60 K(-33.7%) |
| Jun 2018 | - | $453.40 K(-32.8%) |
| Mar 2018 | - | $675.00 K(+1269.2%) |
| Dec 2017 | $49.30 K(-65.0%) | $49.30 K(+45.0%) |
| Nov 2017 | - | $34.00 K(-56.9%) |
| Sep 2017 | - | $78.90 K(+61.0%) |
| Aug 2017 | - | $49.00 K(-50.7%) |
| May 2017 | - | $99.30 K(-29.5%) |
| Feb 2017 | $140.80 K(+1026.4%) | $140.80 K(-15.4%) |
| Dec 2016 | $12.50 K(-53.7%) | - |
| Nov 2016 | - | $166.50 K(>+9900.0%) |
| Aug 2016 | - | $600.00(-89.1%) |
| May 2016 | - | $5500.00(-79.6%) |
| Feb 2016 | $27.00 K(+4400.0%) | $27.00 K(-50.5%) |
| Nov 2015 | - | $54.60 K(+4863.6%) |
| Aug 2015 | - | $1100.00(-84.7%) |
| May 2015 | - | $7200.00(+1100.0%) |
| Feb 2015 | $600.00 | $600.00 |
FAQ
- What is XORTX Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for XORTX Therapeutics?
- What is XORTX Therapeutics annual cash & cash equivalents year-on-year change?
- What is XORTX Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly cash and cash equivalents year-on-year change?
What is XORTX Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of XRTX is $3.45 M
What is the all time high annual cash & cash equivalents for XORTX Therapeutics?
XORTX Therapeutics all-time high annual cash & cash equivalents is $14.79 M
What is XORTX Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, XRTX annual cash & cash equivalents has changed by -$6.96 M (-66.87%)
What is XORTX Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XRTX is $2.30 M
What is the all time high quarterly cash and cash equivalents for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly cash and cash equivalents is $14.87 M
What is XORTX Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, XRTX quarterly cash and cash equivalents has changed by -$1.15 M (-33.27%)